Induced-T Cell Like NK Cellular Immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Induced-T Cell Like NK Cellular Immunotherapy, covering 2024-06-26 to 2024-06-26. Get the full timeline:
Most recent: Clinical Trial Update: Induced-T Cell Like NK Cellular Immunotherapy for Cancer Lack of MHC-I [Phase 1, Phase 2]